Clinical trials for Hereditary angioedema
29 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGN/ANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD · PI: Jessica Stewart, MD
- RECRUITINGPhase 3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc. · PI: Lauge Farnaes, MD
- RECRUITINGN/ANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda · PI: Study Director
- ENROLLING BY INVITATIONPhase 3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPhase 3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc. · PI: Lauge Farnaes, MD
- RECRUITINGN/ANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring · PI: Global Program Director
- RECRUITINGPhase 3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPhase 4NCT06806657Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to GaradacimabCSL Behring · PI: Study Director
- RECRUITINGPhase 1NCT07046806Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema PatientsInstitute for Asthma and Allergy · PI: Henry Li, MD
- ACTIVE NOT RECRUITINGPhase 2NCT06846398A Phase 2 in Adult Subjects With Hereditary AngioedemaShanghai Argo Biopharmaceutical Co., Ltd. · PI: Markus Magerl, Doctor
- RECRUITINGPhase 3NCT06679881Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAEPharvaris Netherlands B.V. · PI: Study Director, Pharvaris
- ACTIVE NOT RECRUITINGPhase 3NCT06634420HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)Intellia Therapeutics
- ACTIVE NOT RECRUITINGPhase 3NCT06669754Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAEPharvaris Netherlands B.V. · PI: Study Director, Pharvaris
- RECRUITINGPhase 3NCT06361537Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema AttacksOctapharma
- ENROLLING BY INVITATIONNCT06262399Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002Intellia Therapeutics
- ACTIVE NOT RECRUITINGPhase 2NCT06007677A Long-term Study of STAR-0215 in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- ACTIVE NOT RECRUITINGN/ANCT05469789A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)Takeda · PI: Study Director
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT05396105Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary AngioedemaPharvaris Netherlands B.V. · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 1NCT05691361Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema PatientsADARx Pharmaceuticals, Inc. · PI: Lauge Farnaes, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05453968Berotralstat Treatment in Children With Hereditary AngioedemaBioCryst Pharmaceuticals · PI: Jolanta Bernatoniene, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05505916An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)KalVista Pharmaceuticals, Ltd. · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 3NCT05511922PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 TrialKalVista Pharmaceuticals, Ltd. · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 3NCT05392114A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)Ionis Pharmaceuticals, Inc.
- ACTIVE NOT RECRUITINGNCT05397431A Survey of Lanadelumab in Participants With Hereditary AngioedemaTakeda · PI: Study Director
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05121376A Gene Therapy Study of BMN 331 in Subjects With Hereditary AngioedemaBioMarin Pharmaceutical · PI: MD Medical Director
- ACTIVE NOT RECRUITINGPhase 1NCT05120830NTLA-2002 in Adults With Hereditary Angioedema (HAE)Intellia Therapeutics
- ENROLLING BY INVITATIONPhase 3NCT04933721Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat StudiesBioCryst Pharmaceuticals · PI: Vesna Grivcheva-Panoska, MD, PhD
- RECRUITINGN/ANCT04334031Deployment o the Multidisciplinary Prospective Cohort ImminentUniversity Hospital, Lille · PI: David Launay, MD,PhD